MA12.Y

ICD-11 MMS 2026-01

Other specified clinical findings of drugs, medicaments or biological substances in blood, blood-forming organs, or the immune system

Exclusions from above levels

  • 3B64 – Thrombocytopenia
  • http://id.who.int/icd/entity/1016799900 – abnormalities of coagulation
  • http://id.who.int/icd/entity/1191191920 – abnormalities of lipids
Show allHide
  • http://id.who.int/icd/entity/1800910986 – Haemorrhagic or haematological disorders of fetus or newborn
  • JA66.0 – Abnormal haematological finding on antenatal screening of mother
  • 19 – Certain conditions originating in the perinatal period
  • JA66 – Clinical findings on antenatal screening of mother

Sibling codes

  • MA12.0 – Finding of opiate drug in blood
  • MA12.1 – Finding of cocaine in blood
  • MA12.2 – Finding of hallucinogen in blood
  • MA12.3 – Finding of psychotropic drug in blood
  • MA12.4 – Finding of steroid agent in blood

Foundation entity

Clinical findings of drugs, medicaments or biological substances in blood, blood-forming organs, or the immune system – http://id.who.int/icd/entity/815226360

Allowed postcoordination axes

Part of: MA12: Clinical findings of drugs, medicaments or biological substances in blood, blood-forming organs, or the immune system › 21: Symptoms, signs or clinical findings, not elsewhere classified